Simulating the restoration of normal gene expression from different thyroid cancer stages using deep learning.
Deep learning
TSPG
Thyroid cancer
Transcriptome
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
04 Jun 2022
04 Jun 2022
Historique:
received:
17
02
2022
accepted:
24
05
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
9
6
2022
Statut:
epublish
Résumé
Thyroid cancer (THCA) is the most common endocrine malignancy and incidence is increasing. There is an urgent need to better understand the molecular differences between THCA tumors at different pathologic stages so appropriate diagnostic, prognostic, and treatment strategies can be applied. Transcriptome State Perturbation Generator (TSPG) is a tool created to identify the changes in gene expression necessary to transform the transcriptional state of a source sample to mimic that of a target. We used TSPG to perturb the bulk RNA expression data from various THCA tumor samples at progressive stages towards the transcriptional pattern of normal thyroid tissue. The perturbations produced were analyzed to determine if there are consistently up- or down-regulated genes or functions in certain stages of tumors. Some genes of particular interest were investigated further in previous research. SLC6A15 was found to be down-regulated in all stage 1-3 samples. This gene has previously been identified as a tumor suppressor. The up-regulation of PLA2G12B in all samples was notable because the protein encoded by this gene belongs to the PLA2 superfamily, which is involved in metabolism, a major function of the thyroid gland. REN was up-regulated in all stage 3 and 4 samples. The enzyme renin encoded by this gene, has a role in the renin-angiotensin system; this system regulates angiogenesis and may have a role in cancer development and progression. This is supported by the consistent up-regulation of REN only in later stage tumor samples. Functional enrichment analysis showed that olfactory receptor activities and similar terms were enriched for the up-regulated genes which supports previous research concluding that abundance and stimulation of olfactory receptors is linked to cancer. TSPG can be a useful tool in exploring large gene expression datasets and extracting the meaningful differences between distinct classes of data. We identified genes that were characteristically perturbed in certain sample types, including only late-stage THCA tumors. Additionally, we provided evidence for potential transcriptional signatures of each stage of thyroid cancer. These are potentially relevant targets for future investigation into THCA tumorigenesis.
Sections du résumé
BACKGROUND
BACKGROUND
Thyroid cancer (THCA) is the most common endocrine malignancy and incidence is increasing. There is an urgent need to better understand the molecular differences between THCA tumors at different pathologic stages so appropriate diagnostic, prognostic, and treatment strategies can be applied. Transcriptome State Perturbation Generator (TSPG) is a tool created to identify the changes in gene expression necessary to transform the transcriptional state of a source sample to mimic that of a target.
METHODS
METHODS
We used TSPG to perturb the bulk RNA expression data from various THCA tumor samples at progressive stages towards the transcriptional pattern of normal thyroid tissue. The perturbations produced were analyzed to determine if there are consistently up- or down-regulated genes or functions in certain stages of tumors.
RESULTS
RESULTS
Some genes of particular interest were investigated further in previous research. SLC6A15 was found to be down-regulated in all stage 1-3 samples. This gene has previously been identified as a tumor suppressor. The up-regulation of PLA2G12B in all samples was notable because the protein encoded by this gene belongs to the PLA2 superfamily, which is involved in metabolism, a major function of the thyroid gland. REN was up-regulated in all stage 3 and 4 samples. The enzyme renin encoded by this gene, has a role in the renin-angiotensin system; this system regulates angiogenesis and may have a role in cancer development and progression. This is supported by the consistent up-regulation of REN only in later stage tumor samples. Functional enrichment analysis showed that olfactory receptor activities and similar terms were enriched for the up-regulated genes which supports previous research concluding that abundance and stimulation of olfactory receptors is linked to cancer.
CONCLUSIONS
CONCLUSIONS
TSPG can be a useful tool in exploring large gene expression datasets and extracting the meaningful differences between distinct classes of data. We identified genes that were characteristically perturbed in certain sample types, including only late-stage THCA tumors. Additionally, we provided evidence for potential transcriptional signatures of each stage of thyroid cancer. These are potentially relevant targets for future investigation into THCA tumorigenesis.
Identifiants
pubmed: 35659616
doi: 10.1186/s12885-022-09704-z
pii: 10.1186/s12885-022-09704-z
pmc: PMC9166476
doi:
Substances chimiques
Amino Acid Transport Systems, Neutral
0
Nerve Tissue Proteins
0
SLC6A15 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
612Informations de copyright
© 2022. The Author(s).
Références
Thyroid. 2016 Nov;26(11):1541-1552
pubmed: 27571228
Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1859-63
pubmed: 19102409
Front Endocrinol (Lausanne). 2020 Mar 13;11:102
pubmed: 32231639
J Cell Biochem. 2021 Aug;122(8):814-826
pubmed: 33690923
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5974-9
pubmed: 12714683
Sci Rep. 2019 Jul 5;9(1):9747
pubmed: 31278367
Lancet. 2016 Dec 3;388(10061):2783-2795
pubmed: 27240885
Int J Med Sci. 2019 Feb 28;16(3):450-460
pubmed: 30911279
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Eur Arch Otorhinolaryngol. 2018 Jun;275(6):1375-1384
pubmed: 29626249
Lancet Diabetes Endocrinol. 2020 Jun;8(6):468-470
pubmed: 32445733
Lancet Oncol. 2019 Feb;20(2):193-201
pubmed: 30583848
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
J Intern Med. 2008 Sep;264(3):224-36
pubmed: 18793332
Nucleic Acids Res. 2019 Jan 8;47(D1):D351-D360
pubmed: 30398656
Nat Rev Endocrinol. 2016 Nov;12(11):646-653
pubmed: 27418023
Br J Cancer. 2008 Feb 12;98(3):587-95
pubmed: 18212756
Nat Genet. 2010 May;42(5):454-8
pubmed: 20400965
Cancer Manag Res. 2019 Apr 11;11:3139-3152
pubmed: 31114356
PLoS One. 2014 Jan 08;9(1):e85110
pubmed: 24416348
J Urol. 1998 Aug;160(2):430-6
pubmed: 9679892
Patterns (N Y). 2020 Aug 17;1(6):100087
pubmed: 33205131
Neoplasia. 2014 Nov 20;16(11):918-27
pubmed: 25425966
Oncol Lett. 2017 Nov;14(5):5059-5068
pubmed: 29098020
Sci Data. 2018 Apr 17;5:180061
pubmed: 29664468
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Gynecol Oncol. 2008 Jun;109(3):418-25
pubmed: 18395779
Front Endocrinol (Lausanne). 2021 Aug 27;12:732726
pubmed: 34512555
Nat Genet. 2003 Mar;33(3):422-5
pubmed: 12567189
Front Endocrinol (Lausanne). 2019 May 08;10:288
pubmed: 31139148
Physiol Rev. 2014 Apr;94(2):355-82
pubmed: 24692351
Sci Rep. 2019 Sep 24;9(1):13736
pubmed: 31551495